{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T20:27:32Z","timestamp":1777148852737,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.expneurol.2012.06.024","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T19:42:50Z","timestamp":1340826170000},"page":"142-146","source":"Crossref","is-referenced-by-count":42,"title":["Recent preclinical evidence advancing cell therapy for Alzheimer's disease"],"prefix":"10.1016","volume":"237","author":[{"given":"Cesar V.","family":"Borlongan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2012.06.024_bb0005","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S1525-0016(16)39764-7","article-title":"Neural stem cell mediated tumor\u2010selective gene delivery: towards high grade glioma clinical trials","volume":"16","author":"Aboody","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0010","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/STROKEAHA.111.618850","article-title":"Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies","volume":"42","author":"Albers","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0361-9230(01)00772-9","article-title":"Stem cells in the treatment of Parkinson's disease","volume":"57","author":"Arenas","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1172\/JCI27120","article-title":"Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A\u03b2 antibody","volume":"116","author":"Bales","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/373339a0","article-title":"Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain","volume":"373","author":"Beck","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0035","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1073\/pnas.022438099","article-title":"Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model","volume":"99","author":"Bjorklund","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0040","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0050","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1517\/13543784.9.10.2319","article-title":"Transplantation therapy for Parkinson's disease","volume":"9","author":"Borlongan","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0055","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S1359-6446(02)02297-3","article-title":"Neural transplantation for treatment of Parkinson's disease","volume":"15","author":"Borlongan","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0045","doi-asserted-by":"crossref","first-page":"SI29","DOI":"10.1016\/S0140-6736(99)90229-5","article-title":"Neural transplantation for neurodegenerative disorders","volume":"353","author":"Borlongan","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0060","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cne.903490110","article-title":"Implants of polymer-encapsulated human NGF-secreting cells in the non-human primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons","volume":"349","author":"Emerich","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0070","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta protein and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/329065a0","article-title":"Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor","volume":"329","author":"Fischer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0080","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/3473","article-title":"Engraftable human neural stem cells respond to developmental cues, replace neurons and express foreign genes","volume":"16","author":"Flax","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0085","doi-asserted-by":"crossref","first-page":"e8314","DOI":"10.1371\/journal.pone.0008314","article-title":"Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies","volume":"4","author":"Frank","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0090","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1073\/pnas.062039699","article-title":"Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?","volume":"99","author":"Freed","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.410380307","article-title":"Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease","volume":"38","author":"Freeman","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0100","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nbt1119","article-title":"Stem and progenitor cell-based therapy of the human central nervous system","volume":"23","author":"Goldman","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/157488810791824421","article-title":"Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme","volume":"5","author":"Gutova","year":"2010","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/gt.2012.12","article-title":"Neural stem cell-mediated CE\/CPT-11 enzyme\/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma","author":"Gutova","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0120","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1523\/JNEUROSCI.06-08-02155.1986","article-title":"NGF promotes survival of septal cholinergic neurons after fimbrial transection","volume":"6","author":"Hefti","year":"1986","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0125","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1371\/journal.pmed.0040262","article-title":"Reducing amyloid plaque burden via ex vivo gene delivery of an A\u03b2-degrading protease: a novel therapeutic approach to Alzheimer disease","volume":"4","author":"Hemming","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/gt.2009.80","article-title":"Intrathecal transplantation of human neural stem cells overexpressing VEGF provides behavioral improvement, disease onset delay and survival extension in transgenic ALS mice","volume":"16","author":"Hwang","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0135","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain A\u03b2 by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0140","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1096\/fj.03-0927fje","article-title":"Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derived nestinpositive cells","volume":"18","author":"Jung","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0145","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1523\/JNEUROSCI.13-12-05203.1993","article-title":"Regulation of dopamine production by genetically modified primary fibroblasts","volume":"13","author":"Kang","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1440-1789.2004.00552.x","article-title":"Human neural stem cells genetically modified for brain repair in neurological disorders","volume":"24","author":"Kim","year":"2004","journal-title":"Neuropathology"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0155","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/jnr.22054","article-title":"Stem cell-based cell therapy in neurological diseases: a review","volume":"87","author":"Kim","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0160","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199504273321702","article-title":"Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease","volume":"332","author":"Kordower","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI24012","article-title":"The promise of stem cells in Parkinson disease","volume":"115","author":"Langston","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0170","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1371\/journal.pone.0000156","article-title":"Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model","volume":"1","author":"Lee","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/brain\/awm306","article-title":"Anti-inflammatory mechanism of intravascular neural stem cell transplantation in hemorrhagic stroke","volume":"131","author":"Lee","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0180","doi-asserted-by":"crossref","first-page":"e5586","DOI":"10.1371\/journal.pone.0005586","article-title":"Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model","volume":"4","author":"Lee","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0185","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/gt.2009.51","article-title":"Human neural stem cells overexpressing glial cell line derived neurotrophic factor (GDNF) promote functional recovery and neuroprotection in experimental cerebral hemorrhage","volume":"16","author":"Lee","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0190","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1002\/jnr.22474","article-title":"Human neural stem cells genetically modified to overexpress BDNF promote functional recovery and neuroprotection in mouse stroke model","volume":"88","author":"Lee","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0195","doi-asserted-by":"crossref","DOI":"10.3727\/096368912X638964","article-title":"Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in mouse with ibotenic acid-induced cognitive dysfunction","author":"Lee","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1602\/neurorx.1.4.382","article-title":"Cell therapy in Parkinson's disease","volume":"1","author":"Lindvall","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0215","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nature04960","article-title":"Stem cells for the treatment of neurological disorders","volume":"441","author":"Lindvall","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0200","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(88)90950-6","article-title":"Fetal dopamine-rich mesencephalic grafts in Parkinson's disease","volume":"2","author":"Lindvall","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.410310206","article-title":"Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants","volume":"31","author":"Lindvall","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJM198801073180115","article-title":"Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease","volume":"318","author":"Madrazo","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0225","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1523\/JNEUROSCI.23-06-01992.2003","article-title":"Neprilysin gene transfer reduces human amyloid pathology in transgenic mice","volume":"23","author":"Marr","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0230","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1523\/JNEUROSCI.23-26-08867.2003","article-title":"The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta degradation and inhibits A\u03b2-induced neurodegeneration","volume":"23","author":"Melchor","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0235","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1073\/pnas.1031520100","article-title":"Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0240","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","article-title":"Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease","volume":"51","author":"Mueller-Steiner","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.expneurol.2011.12.040","article-title":"Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction","volume":"234","author":"Park","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0250","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3727\/096368911X586765","article-title":"Human neural stem cells overexpressing choline acetyltransferase restore cognitive function of kainic acid-induced learning and memory deficit animals","volume":"21","author":"Park","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0255","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.neuroscience.2004.11.048","article-title":"Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog","volume":"131","author":"Rafuse","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0260","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/STROKEAHA.110.601914","article-title":"Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II","volume":"42","author":"Savitz","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0265","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.STR.31.9.2212","article-title":"Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia","volume":"31","author":"Sch\u00e4bitz","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0270","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1593\/neo.04781","article-title":"Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor","volume":"7","author":"Schmidt","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2011.07.001","article-title":"Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer","volume":"311","author":"Seol","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0280","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/sj.gt.3302932","article-title":"Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma","volume":"14","author":"Shimato","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0285","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.wco.0000174298.27765.91","article-title":"Stem cell treatment for Parkinson's disease: an update for 2005","volume":"18","author":"Snyder","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.molbrainres.2004.09.002","article-title":"Stem cells may reshape the prospect of Parkinson's disease therapy","volume":"134","author":"Sonntag","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijdevneu.2008.08.002","article-title":"Long-term functional restoration by neural progenitor cell transplantation in rat model of cognitive dysfunction: co-transplantation with olfactory ensheathing cells for neurotrophic factor support","volume":"27","author":"Srivastava","year":"2009","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0300","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1545968309335978","article-title":"The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion","volume":"23","author":"Stroemer","year":"2009","journal-title":"Neurorehabil. Neural Repair"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0305","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1172\/JCI21137","article-title":"Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model","volume":"115","author":"Takagi","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0315","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1474-4422(02)00006-6","article-title":"Gene therapy for neurodegenerative disorders","volume":"1","author":"Tuszynski","year":"2002","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0310","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1523\/JNEUROSCI.10-11-03604.1990","article-title":"Nerve growth factor infusion in primate brain reduces lesion-induced cholinergic neuronal degeneration","volume":"10","author":"Tuszynski","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0320","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0325","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0330","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000124979","article-title":"Neural stem cells improve learning and memory in rats with Alzheimer's disease","volume":"75","author":"Wu","year":"2008","journal-title":"Pathobiology"},{"key":"10.1016\/j.expneurol.2012.06.024_bb0335","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neulet.2008.05.107","article-title":"BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornix","volume":"440","author":"Xuan","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0340","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1523\/JNEUROSCI.3719-06.2006","article-title":"Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease","volume":"26","author":"Yasuhara","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0345","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1089\/scd.2009.0011","article-title":"Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals","volume":"18","author":"Yasuhara","year":"2009","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.expneurol.2012.06.024_bb0350","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/stem.784","article-title":"Human neural stem cell tropism to metastatic breast cancer","volume":"30","author":"Zhao","year":"2012","journal-title":"Stem Cells"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861200266X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861200266X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T09:58:55Z","timestamp":1561888735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448861200266X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S001448861200266X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2012.06.024","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}